Open AccessLiposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial: Erratum
Publication year - 2020
Publication title -
pancreas
Language(s) - English
Resource type - Journals
eISSN - 1536-4828
pISSN - 0885-3177
DOI - 10.1097/mpa.0000000000001517
Subject(s) - irinotecan , medicine , oncology , pancreatic cancer , subgroup analysis , cancer , clinical trial , colorectal cancer , meta analysis